Therapeutics, Inc.
31
0
0
30
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
3.2%
1 terminated/withdrawn out of 31 trials
96.8%
+10.3% vs industry average
26%
8 trials in Phase 3/4
50%
15 of 30 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
Role: collaborator
Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
Role: collaborator
Study of TDM-180935 in Atopic Dermatitis Patients
Role: collaborator
Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis
Role: collaborator
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
Role: lead
A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects
Role: collaborator
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
Role: collaborator
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
Role: collaborator
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Role: collaborator
Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis
Role: collaborator
Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
Role: collaborator
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
Role: collaborator
A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
Role: lead
A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis
Role: lead
A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne
Role: collaborator
A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
Role: lead
Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)
Role: lead
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
Role: lead
A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris
Role: lead
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)
Role: lead